RxDoctor Payments Data

Uyen Ngoc Mui, MD

Dermatology · Katy, TXNPI 1033572136

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,513 of the $13,588 with a category attached, or 77.4%. It is spread thinly across 30 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.

$13,588in general payments, 2019–2025

Across 416 payments — averaging $32.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Sanofi$2K
  • Eli Lilly$2K
  • Amgen$1K
  • Regeneron Healthcare Solutions, Inc.$852
  • Johnson & Johnson$726
  • plus $5K from 24 others
$315,101in research payments, 2019–2025

Across 8 payments — averaging $39,388 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$232K
  • Eli Lilly$83K

What the payments were for

  • Consulting fees$1,51211%
  • Travel & lodging$1,1518%
  • Food & beverage$10,51377%
  • Education$4123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,588 in reported general payments places this provider in the 75th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$48,423
Medicare patients
169
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus34$4,780
Clobetasol Propionate83$3,277
Hydroxychloroquine Sulfate15$1,481
Doxycycline Monohydrate33$1,394
Ketoconazole51$880
Fluocinolone Acetonide13$702
Triamcinolone Acetonide69$572
Hydrocortisone50$364
Minoxidil24$314
Spironolactone11$200
Nystatin16$193
Finasteride18$122
Fluconazole11$53

Paid to pharmacies, not to this prescriber.

Other dermatology in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →